Nanomedicine for Cancer Immunotherapy: Tracking Cancer-Specific T-Cells in Vivo with Gold Nanoparticles and CT Imaging

ACS Nano

Volumn 9, Issue 6, 2015, Pages 6363-6372

  Meir, Rinat ^a   Shamalov, Katerina ^a   Betzer, Oshra ^a   Motiei, Menachem ^a   Horovitz Fried, Miryam ^a   Yehuda, Ronen ^a   Popovtzer, Aron ^b   Popovtzer, Rachela ^a   Cohen, Cyrille J ^a  

^a BAR ILAN UNIVERSITY   (Israel)

^b RABIN MEDICAL CENTER   (Israel)

Author keywords

cancer; cell therapy; cell tracking; computed tomography; imaging; immunotherapy; T cells

Indexed keywords

CELL MEMBRANES; CELLS; CYTOLOGY; DERMATOLOGY; DISEASES; FIBER OPTIC SENSORS; FLUORESCENCE; GOLD; IMAGING TECHNIQUES; MEDICAL NANOTECHNOLOGY; METAL NANOPARTICLES; NANOPARTICLES; ONCOLOGY; T-CELLS; TOMOGRAPHY; TUMORS;

CANCER; CELL THERAPY; CELL TRACKING; FLUORESCENCE IMAGING; GOLD NANOPARTICLES (GNPS); GREEN FLUORESCENT PROTEIN; IMMUNOTHERAPY; X-RAY COMPUTED TOMOGRAPHY;

COMPUTERIZED TOMOGRAPHY;

GOLD; METAL NANOPARTICLE;

ANIMAL; CELL TRACKING; CHEMISTRY; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HEK293 CELL LINE; HUMAN; IMMUNOLOGY; IMMUNOTHERAPY; MOUSE; NANOMEDICINE; NEOPLASMS; NUDE MOUSE; T LYMPHOCYTE; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; CELL TRACKING; FEMALE; GOLD; HEK293 CELLS; HUMANS; IMMUNOTHERAPY; METAL NANOPARTICLES; MICE; MICE, NUDE; NANOMEDICINE; NEOPLASMS; T-LYMPHOCYTES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84934896807     PISSN: 19360851     EISSN: 1936086X     Source Type: Journal    
DOI: 10.1021/acsnano.5b01939     Document Type: Article

References (48)

1. Ahrens, E. T.; Bulte, J. W. M. Tracking Immune Cells in Vivo Using Magnetic Resonance Imaging Nature Rev. Immunol. 2013, 13, 755-763
2. Janowski, M.; Bulte, J. W. M.; Walczak, P. Personalized Nanomedicine Advancements for Stem Cell Tracking Adv. Drug Delivery Rev. 2012, 64, 1488-1507
3. Lindvall, O.; Björklund, A. Cell Therapy in Parkinson's Disease NeuroRx 2004, 1, 382-393
4. Bongso, A.; Fong, C.-Y.; Gauthaman, K. Taking Stem Cells to the Clinic: Major Challenges J. Cell. Biochem. 2008, 105, 1352-1360
5. Tong, L.; Zhao, H.; He, Z.; Li, Z. Current Perspectives on Molecular Imaging for Tracking Stem Cell Therapy. In Medical Imaging in Clinical Practice; ERondu, O. F., Ed. Intech: Rijeka, Croatia, 2013; Chapter 4.
6. Srivastava, A. K.; Bulte, J. W. M. Seeing Stem Cells at Work in Vivo Stem Cell Rev. 2014, 10, 127-144
7. Jha, P.; Golovko, D.; Bains, S.; Hostetter, D.; Meier, R.; Wendland, M. F.; Daldrup-link, H. E. Monitoring of NK-Cell Immunotherapy Using Non-Invasive Imaging Modalities Cancer Res. 2011, 70, 6109-6113
8. Shilo, M.; Reuveni, T.; Motiei, M.; Popovtzer, R. Nanoparticles as Computed Tomography Contrast Agents: Current Status and Future Perspectives Nanomedicine (London) 2012, 7, 257-269
9. Yu, S. B.; Watson, a D. Metal-Based X-Ray Contrast Media Chem. Rev. 1999, 99, 2353-2378
10. Khan, M. S.; Vishakante, G. D.; Siddaramaiah, H. Gold Nanoparticles: A Paradigm Shift in Biomedical Applications Adv. Colloid Interface Sci. 2013, 199-200, 44-58
11. Nam, S. Y.; Ricles, L. M.; Sokolov, K.; Suggs, L. J.; Emelianov, S. Y. Ultrasound and Photoacoustic Imaging to Monitor Mesenchymal Stem Cells Labeled with Gold Nanoparticles Proc. SPIE 2011, Photons Plus Ultrasound: Imaging and Sensing 2011, 78991Z
12. Chung, E.; Nam, S. Y.; Ricles, L. M.; Emelianov, S. Y.; Suggs, L. J. Evaluation of Gold Nanotracers to Track Adipose-Derived Stem Cells in a PEGylated Fibrin Gel for Dermal Tissue Engineering Applications Int. J. Nanomed. 2013, 8, 325-336
13. Nam, S. Y.; Ricles, L. M.; Suggs, L. J.; Emelianov, S. Y. In Vivo Ultrasound and Photoacoustic Monitoring of Mesenchymal Stem Cells Labeled with Gold Nanotracers PLoS One 2012, 7, e37267
14. Jokerst, J. V.; Thangaraj, M.; Kempen, P. J.; Sinclair, R.; Sanjiv, S. Photoacoustic Imaging of Mesenchymal Stem Cells in Living Mice via Silica-Coated Gold Nanorods ACS Nano 2013, 6, 5920-5930
15. Meir, R.; Motiei, M.; Popovtzer, R. Gold Nanoparticles for in Vivo Cell Tracking Nanomedicine (London) 2014, 9, 2059-2069
16. Menk, R. H.; Schültke, E.; Hall, C.; Arfelli, F.; Astolfo, A.; Rigon, L.; Round, A.; Ataelmannan, K.; MacDonald, S. R.; Juurlink, B. H. J. Gold Nanoparticle Labeling of Cells Is a Sensitive Method to Investigate Cell Distribution and Migration in Animal Models of Human Disease Nanomedicine 2011, 7, 647-654
17. Astolfo, A.; Schültke, E.; Menk, R. H.; Kirch, R. D.; Juurlink, B. H. J.; Hall, C.; Harsan, L.-A.; Stebel, M.; Barbetta, D.; Tromba, G.; Arfelli, F. In Vivo Visualization of Gold-Loaded Cells in Mice Using X-Ray Computed Tomography Nanomedicine: Nanotechnol., Biol. Med. 2013, 9, 284-292
18. Schültke, E.; Menk, R.; Pinzer, B.; Astolfo, A.; Stampanoni, M.; Arfelli, F.; Harsan, L.-A.; Nikkhah, G. Single-Cell Resolution in High-Resolution Synchrotron X-Ray CT Imaging with Gold Nanoparticles J. Synchrotron Radiat. 2014, 21, 242-250
19. Astolfo, A.; Arfelli, F.; Schültke, E.; James, S.; Mancini, L.; Menk, R.-H. A Detailed Study of Gold-Nanoparticle Loaded Cells Using X-Ray Based Techniques for Cell-Tracking Applications with Single-Cell Sensitivity Nanoscale 2013, 5, 3337-3345
20. Shilo, M.; Motiei, M.; Hana, P.; Popovtzer, R. Transport of Nanoparticles through the Blood-Brain Barrier for Imaging and Therapeutic Applications Nanoscale 2014, 6, 2146-2152
21. Wang, Y.; Xu, C.; Ow, H. Commercial Nanoparticles for Stem Cell Labeling and Tracking Theranostics 2013, 3, 544-560
22. Rosenberg, S. A.; Restifo, N. P. Adoptive Cell Transfer as Personalized Immunotherapy for Human Cancer Science 2015, 348, 62-68
23. Chen, Y.-S.; Shen, C.-R. Immune Checkpoint Blockade Therapy: The 2014 Tang Prize in Biopharmaceutical Science Biomed. J. 2015, 38, 5-8
24. Ascierto, P. A. Immunotherapies and Novel Combinations: The Focus of Advances in the Treatment of Melanoma Cancer Immunol. Immunother. 2014, 64, 271-274
25. Weber, J.; Atkins, M.; Hwu, P.; Radvanyi, L.; Sznol, M.; Yee, C. Immunotherapy Task Force of the NCI Investigational Drug Steering Committee. White Paper on Adoptive Cell Therapy for Cancer with Tumor-Infiltrating Lymphocytes: A Report of the CTEP Subcommittee on Adoptive Cell Therapy Clin. Cancer Res. 2011, 17, 1664-1673
26. Rosenberg, S. A.; Dudley, M. E. Adoptive Cell Therapy for the Treatment of Patients with Metastatic Melanoma Curr. Opin. Immunol. 2009, 21, 233-240
27. Johnson, L. A.; Morgan, R. A.; Dudley, M. E.; Cassard, L.; Yang, J. C.; Hughes, M. S.; Kammula, U. S.; Royal, R. E.; Sherry, R. M.; Wunderlich, J. R.; Lee, C.-C. R.; Restifo, N. P.; Schwarz, S. L.; Cogdill, A. P.; Bishop, R. J.; Kim, H.; Brewer, C. C.; Rudy, S. F.; VanWaes, C.; Davis, J. L.; Mathur, A.; Ripley, R. T.; Nathan, D. A.; Laurencot, C. M.; Rosenberg, S. A. Gene Therapy with Human and Mouse T-Cell Receptors Mediates Cancer Regression and Targets Normal Tissues Expressing Cognate Antigen Blood 2009, 114, 535-546
28. Restifo, N. P.; Dudley, M. E.; Rosenberg, S. A. Adoptive Immunotherapy for Cancer: Harnessing the T Cell Response Nature Rev. Immunol. 2012, 12, 269-281
29. Merhavi-Shoham, E.; Haga-Friedman, A.; Cohen, C. J. Genetically Modulating T-Cell Function to Target Cancer Semin. Cancer Biol. 2012, 22, 14-22
30. Daniel-Meshulam, I.; Ya'akobi, S.; Ankri, C.; Cohen, C. J. How (specific) Would like Your T-Cells Today? Generating T-Cell Therapeutic Function through TCR-Gene Transfer Front. Immunol. 2012, 3, 186
31. Morgan, R. A.; Dudley, M. E.; Wunderlich, J. R.; Hughes, M. S.; Yang, J. C.; Sherry, R. M.; Royal, R. E.; Topalian, S. L.; Kammula, U. S.; Restifo, N. P.; Zheng, Z.; Nahvi, A.; de Vries, C. R.; Rogers-Freezer, L. J.; Mavroukakis, S. A.; Rosenberg, S. A. Cancer Regression in Patients after Transfer of Genetically Engineered Lymphocytes Science 2006, 314, 126-129
32. Cohen, C. J.; Zhao, Y.; Zheng, Z.; Rosenberg, S. A.; Morgan, R. A. Enhanced Antitumor Activity of Murine-Human Hybrid T-Cell Receptor (TCR) in Human Lymphocytes Is Associated with Improved Pairing and TCR/CD3 Stability Cancer Res. 2006, 66, 8878-8886
33. Cohen, C. J.; Li, Y. F.; El-Gamil, M.; Robbins, P. F.; Rosenberg, S. A.; Morgan, R. A. Enhanced Antitumor Activity of T Cells Engineered to Express T-Cell Receptors with a Second Disulfide Bond Cancer Res. 2007, 67, 3898-3903
34. Bialer, G.; Horovitz-Fried, M.; Ya'acobi, S.; Morgan, R. A.; Cohen, C. J. Selected Murine Residues Endow Human TCR with Enhanced Tumor Recognition J. Immunol. 2010, 184, 6232-6241
35. Haga-Friedman, A.; Horovitz-Fried, M.; Cohen, C. J. Incorporation of Transmembrane Hydrophobic Mutations in the TCR Enhance Its Surface Expression and T Cell Functional Avidity J. Immunol. 2012, 188, 5538-5546
36. Daniel-Meshulam, I.; Horovitz-Fried, M.; Cohen, C. J. Enhanced Antitumor Activity Mediated by Human 4-1BB-Engineered T Cells Int. J. Cancer 2013, 133, 2903-2913
37. Ankri, C.; Shamalov, K.; Horovitz-Fried, M.; Mauer, S.; Cohen, C. J. Human T Cells Engineered to Express a Programmed Death 1/28 Costimulatory Retargeting Molecule Display Enhanced Antitumor Activity J. Immunol. 2013, 191, 4121-4129
38. Betzer, O.; Shwartz, A.; Motiei, M.; Kazimirsky, G.; Gispan, I.; Damti, E.; Brodie, C.; Yadid, G.; Popovtzer, R. Nanoparticle-Based CT Imaging Technique for Longitudinal and Quantitative Stem Cell Tracking within the Brain: Application in Neuropsychiatric Disorders ACS Nano 2014, 8, 9274-9285
39. Enustun, B. V.; Turkevich, J. Coagulation of Colloidal Gold J. Am. Chem. Soc. 1963, 85, 3317-3328
40. Popovtzer, R.; Agrawal, A.; Kotov, N. a; Popovtzer, A.; Balter, J.; Carey, T. E.; Kopelman, R. Targeted Gold Nanoparticles Enable Molecular CT Imaging of Cancer Nano Lett. 2008, 8, 4593-4596
41. Hughes, M. S.; Yu, Y. Y. L.; Dudley, M. E.; Zheng, Z.; Robbins, P. F.; Li, Y.; Wunderlich, J.; Hawley, R. G.; Moayeri, M.; Rosenberg, S. A.; Morgan, R. A. Transfer of a TCR Gene Derived from a Patient with a Marked Antitumor Response Conveys Highly Active T-Cell Effector Functions Hum. Gene Ther. 2005, 16, 457-472
42. Gu, E.; Chen, W.-Y.; Gu, J.; Burridge, P.; Wu, J. C. Molecular Imaging of Stem Cells: Tracking Survival, Biodistribution, Tumorigenicity, and Immunogenicity Theranostics 2012, 2, 335-345
43. Gastman, B. R.; Johnson, D. E.; Whiteside, T. L.; Rabinowich, H. Tumor-Induced Apoptosis of T Lymphocytes: Elucidation of Intracellular Apoptotic Events Blood 2000, 95, 2015-2023
44. Meyerrose, T. E.; Herrbrich, P.; Hess, D. A.; Nolta, J. A. Immune-Deficient Mouse Models for Analysis of Human Stem Cells Biotechniques 2003, 35, 1262-1272
45. Topalian, S. L.; Solomon, D.; Rosenberg, S. A. Tumor-Specific Cytolysis by Lymphocytes Infiltrating Human Melanomas J. Immunol. 1989, 142, 3714-3725
46. Houghton, A. N.; Real, F. X.; Davis, L. J.; Cordon-Cardo, C.; Old, L. J. Phenotypic Heterogeneity of Melanoma. Relation to the Differentiation Program of Melanoma Cells J. Exp. Med. 1987, 165, 812-829
47. Wargo, J. A.; Robbins, P. F.; Li, Y.; Zhao, Y.; El-Gamil, M.; Caragacianu, D.; Zheng, Z.; Hong, J. A.; Downey, S.; Schrump, D. S.; Rosenberg, S. A.; Morgan, R. A. Recognition of NY-ESO-1+ Tumor Cells by Engineered Lymphocytes Is Enhanced by Improved Vector Design and Epigenetic Modulation of Tumor Antigen Expression Cancer Immunol. Immunother. 2009, 58, 383-394
48. Goff, S. L.; Johnson, L. A.; Black, M. A.; Xu, H.; Zheng, Z.; Cohen, C. J.; Morgan, R. A.; Rosenberg, S. A.; Feldman, S. A. Enhanced Receptor Expression and in Vitro Effector Function of a Murine-Human Hybrid MART-1-Reactive T Cell Receptor Following a Rapid Expansion Cancer Immunol. Immunother. 2010, 59, 1551-1560